Nhs_choices Bthft Bradford Teaching HospitalsNHS Foundation Trust NHS Choices
  • Text Size

  • Language

    loading

05 - Infections

NICE Technologies Applicable to this BNF Section
TA Number TA Subject Has the recommendation in the TA been implemented in the organisation for example by changes to the local formulary for drugs, procurement of devices or changes to care pathways? (Yes/No/TA Not Applicable to this organisation)
TA300 Hepatits C (children and young people) - peginterferon alfa and ribavirin (TA300) Implementation in progress
TA276 Cystic Fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin (TA276) Yes
TA253
Hepatits C (genotype 1) - boceprevir (TA253)
Yes
TA252
Hepatits C (genotype 1) - Telaprevir (TA252) Yes
TA200
Hepatitis C - peginterferon alfa and ribavirin (TA200) Yes
TA173
Hepatitis B - tenofovir disoproxil fumarate (TA173)
Yes
TA168
Influenza - zanamivir, amantadine and oseltamivir (review) (TA168) Yes
TA158 Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir (TA158) Yes
TA154 Hepatitis B - telbivudine (TA154) Yes
TA153 Hepatitis B - entecavir (TA153) Yes
TA106 Hepatitis C - peginterferon and ribavirin (TA106) Yes
TA96 Hepatitis B (chronic) - adefovir dipivoxil and interferon alfa-2a (TA96) Yes
TA75 Hepatitis C - pegylated interferons, ribavirin and alfa interferon (TA75) Yes